Oruka Therapeutics (ORKA) Other financing activities (2010 - 2024)
Oruka Therapeutics' quarterly Other financing activities came in at -$174000.0 in Q4 2024, down 100.08% quarter-over-quarter from $226.5 million in Q3 2024.
Oruka Therapeutics has reported Other financing activities for 12 years, with the latest figure at -$174000.0 in Q4 2024.
- For the quarter ending Q4 2024, Other financing activities changed N/A year-over-year to -$174000.0; the trailing twelve-month figure through Dec 2024 stood at $228.0 million (changed N/A YoY), and the FY2024 full-year result was $228.0 million, changed N/A from the prior year.
- Other financing activities for Q4 2024 stood at -$174000.0, down from $226.5 million in the prior quarter.
- The five-year high for Other financing activities was $226.5 million in Q3 2024, with the low at -$174000.0 in Q4 2024.
- Average Other financing activities over 3 years is $32.9 million, with a median of $977000.0 recorded in 2021.
- Peak annual rise in Other financing activities reached 3125.0% in 2020, while the deepest fall reached 1617.28% in 2020.
- Tracing ORKA's Other financing activities over 3 years: stood at $129000.0 in 2020, then surged by 657.36% to $977000.0 in 2021, then slumped by 117.81% to -$174000.0 in 2024.
- The last three Other financing activities figures came in at -$174000.0 (Q4 2024), $226.5 million (Q3 2024), and $1.5 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -174,000.00 |
| Dec 31, 2024 | -174,000.00 |
| Sep 30, 2024 | 226.54 Mn |
| Sep 30, 2024 | 226.54 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Mar 31, 2021 | 977,000.00 |
| Mar 31, 2021 | 977,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Dec 31, 2020 | 129,000.00 |
| Sep 30, 2020 | 1.39 Mn |
| Sep 30, 2020 | 1.39 Mn |
| Dec 31, 2019 | 4,000.00 |
| Dec 31, 2019 | 4,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Sep 30, 2019 | 81,000.00 |
| Jun 30, 2019 | 170,000.00 |
| Jun 30, 2019 | 170,000.00 |
| Mar 31, 2019 | 117,000.00 |
| Mar 31, 2019 | 117,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Jun 30, 2018 | 1,000.00 |
| Mar 31, 2018 | 116,000.00 |
| Mar 31, 2018 | 116,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Dec 31, 2017 | 29,000.00 |
| Sep 30, 2017 | 198,000.00 |
| Sep 30, 2017 | 198,000.00 |
| Jun 30, 2017 | 116,000.00 |
| Jun 30, 2017 | 116,000.00 |
| Mar 31, 2017 | 105,000.00 |
| Mar 31, 2017 | 105,000.00 |
| Dec 31, 2015 | -2.76 Mn |
| Dec 31, 2015 | -2.76 Mn |
| Sep 30, 2015 | 145,000.00 |
| Sep 30, 2015 | 145,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Dec 31, 2014 | 2,000.00 |
| Mar 31, 2014 | 834,000.00 |
| Mar 31, 2014 | 834,000.00 |
| Dec 31, 2013 | 2.10 Mn |
| Dec 31, 2013 | 2.10 Mn |
| Sep 30, 2013 | -358,000.00 |
| Sep 30, 2013 | -358,000.00 |
| Jun 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 30,000.00 |
| Mar 31, 2013 | 308,000.00 |
| Mar 31, 2013 | 308,000.00 |
| Dec 31, 2012 | 67,000.00 |
| Dec 31, 2012 | 67,000.00 |
| Sep 30, 2012 | 211,000.00 |
| Sep 30, 2012 | 211,000.00 |
| Jun 30, 2012 | 1,000.00 |
| Jun 30, 2012 | 1,000.00 |
| Mar 31, 2012 | 60,000.00 |
| Mar 31, 2012 | 60,000.00 |
| Dec 31, 2011 | 250,000.00 |
| Dec 31, 2011 | 250,000.00 |
| Sep 30, 2011 | -8,000.00 |
| Sep 30, 2011 | -8,000.00 |
| Dec 31, 2010 | 120,000.00 |
| Dec 31, 2010 | 120,000.00 |